Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M H Gail

Showing results (91-100 of 141) with videos related to

Pageof 15
Sort By:
Statistics in Medicine|June 15, 1996
On design considerations and randomization-based inference for community intervention trialsM H Gail, S D Mark, R J Carroll, et al.
Cancer Treatment Reports|October 1, 1987
Pilot study of induction therapy with cyclophosphamide, doxorubicin, and cisplatin (CAP) and chest irradiation prior to thoracotomy in initially inoperable stage III M0 non-small cell lung cancerR T Eagan, C Ruud, R E Lee, et al.
American Journal of Epidemiology|October 1, 1982
Age and sex as factors influencing remission duration in African Burkitt's lymphomaR J Biggar, M H Gail, R B Banks, et al.
Annals of Internal Medicine|July 1, 1987
Natural history of human immunodeficiency virus infections in hemophiliacs: effects of T-cell subsets, platelet counts, and ageM E Eyster, M H Gail, J O Ballard, et al.
Annals of Internal Medicine|June 15, 1989
Predictive markers for the acquired immunodeficiency syndrome (AIDS) in hemophiliacs: persistence of p24 antigen and low T4 cell countM E Eyster, J O Ballard, M H Gail, et al.
Journal of the National Cancer Institute|November 5, 1999
Weighing the risks and benefits of tamoxifen treatment for preventing breast cancerM H Gail, J P Costantino, J Bryant, et al.
Journal of the National Cancer Institute|April 6, 2000
Re: Risk/benefit assessment of tamoxifen to prevent breast cancer-still a work in progress?M H Gail, J P Costantino, J Bryant, et al.
Journal of the National Cancer Institute|July 1, 1980
Human placental and pituitary glycoprotein hormones and their subunits as tumor markers: a quantitative assessmentM R Blackman, B D Weintraub, S W Rosen, et al.
Biometrics|December 1, 1994
A nonparametric analysis of the transmission rate of human immunodeficiency virus from mother to infantW Y Tsai, J J Goedert, J Orazem, et al.
Journal of the National Cancer Institute|September 24, 1999
Validation studies for models projecting the risk of invasive and total breast cancer incidenceJ P Costantino, M H Gail, D Pee, et al.
Pageof 15

Showing results (91-100 of 141) with videos related to

Sort By:
Pageof 15
Statistics in Medicine|June 15, 1996
On design considerations and randomization-based inference for community intervention trialsM H Gail, S D Mark, R J Carroll, et al.
Cancer Treatment Reports|October 1, 1987
Pilot study of induction therapy with cyclophosphamide, doxorubicin, and cisplatin (CAP) and chest irradiation prior to thoracotomy in initially inoperable stage III M0 non-small cell lung cancerR T Eagan, C Ruud, R E Lee, et al.
American Journal of Epidemiology|October 1, 1982
Age and sex as factors influencing remission duration in African Burkitt's lymphomaR J Biggar, M H Gail, R B Banks, et al.
Annals of Internal Medicine|July 1, 1987
Natural history of human immunodeficiency virus infections in hemophiliacs: effects of T-cell subsets, platelet counts, and ageM E Eyster, M H Gail, J O Ballard, et al.
Annals of Internal Medicine|June 15, 1989
Predictive markers for the acquired immunodeficiency syndrome (AIDS) in hemophiliacs: persistence of p24 antigen and low T4 cell countM E Eyster, J O Ballard, M H Gail, et al.
Journal of the National Cancer Institute|November 5, 1999
Weighing the risks and benefits of tamoxifen treatment for preventing breast cancerM H Gail, J P Costantino, J Bryant, et al.
Journal of the National Cancer Institute|April 6, 2000
Re: Risk/benefit assessment of tamoxifen to prevent breast cancer-still a work in progress?M H Gail, J P Costantino, J Bryant, et al.
Journal of the National Cancer Institute|July 1, 1980
Human placental and pituitary glycoprotein hormones and their subunits as tumor markers: a quantitative assessmentM R Blackman, B D Weintraub, S W Rosen, et al.
Biometrics|December 1, 1994
A nonparametric analysis of the transmission rate of human immunodeficiency virus from mother to infantW Y Tsai, J J Goedert, J Orazem, et al.
Journal of the National Cancer Institute|September 24, 1999
Validation studies for models projecting the risk of invasive and total breast cancer incidenceJ P Costantino, M H Gail, D Pee, et al.
Pageof 15